Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ionizing radiation and cardiovascular disease.

David G Hoel1

  • 1Medical University of South Carolina, Charleston, SC 29401, USA. hoel@musc.edu

Annals of the New York Academy of Sciences
|November 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beneficial health effects of ultraviolet radiation: expert review and conference report.

Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology·2025
Same author

Insufficient Sun Exposure Has Become a Real Public Health Problem.

International journal of environmental research and public health·2020
Same author

Administration of lower doses of radium-224 to ankylosing spondylitis patients results in no evidence of significant overall detriment.

PloS one·2020
Same author

Sun Exposure Public Health Directives.

International journal of environmental research and public health·2018
Same author

Quantitative Risk Assessment in the 1970s: A Personal Remembrance.

Dose-response : a publication of International Hormesis Society·2018
Same author

Nuclear epidemiologic studies and the estimation of DREF.

International journal of radiation biology·2018

Radiation exposure increases noncancer mortality, primarily from circulatory diseases, particularly cardiovascular disease. Studies show measurable risks at doses over 0.5 Sv, linked to inflammation and arterial damage.

Area of Science:

  • Radiological Health
  • Cardiovascular Epidemiology
  • Radiation Biology

Background:

  • A-bomb survivor studies indicate elevated noncancer mortality following radiation exposure.
  • Circulatory disease mortality is the most significant contributor to this increase.
  • Atherosclerosis, an inflammatory arterial disease, is a known risk factor for myocardial infarction.

Purpose of the Study:

  • To examine the link between radiation exposure and noncancer mortality, focusing on circulatory diseases.
  • To assess cardiovascular disease mortality risks in populations exposed to radiation.
  • To investigate the dose-response relationship for radiation-induced circulatory issues.

Main Methods:

  • Analysis of mortality data from A-bomb survivors and occupational cohorts.

Related Experiment Videos

  • Evaluation of cardiovascular disease mortality rates relative to radiation dose.
  • Assessment of immunological markers for inflammation in relation to radiation dose.
  • Review of animal studies on radiation effects on cardiovascular health and arterial damage.

    • Main Results:

    • A-bomb survivor studies demonstrate increased noncancer mortality due to radiation, with circulatory disease being prominent.
    • Measurable increases in cardiovascular disease mortality are observed at radiation doses exceeding 0.5 Sv.
    • Immunological markers for inflammation show a dose-related response in A-bomb survivors.
    • Animal studies confirm increased cardiovascular mortality and arterial endothelial damage from neutron and gamma radiation.

    Conclusions:

    • Radiation exposure is a significant risk factor for noncancer mortality, especially cardiovascular disease.
    • Cardiovascular disease mortality risk increases with radiation dose, even at levels below those for solid cancers.
    • Radiation-induced inflammation and arterial damage contribute to increased circulatory disease risk.